About Michelson Diagnostics
Michelson Diagnostics is a company based in Maidstone (United Kingdom) founded in 2006. It operates as a B2B. Michelson Diagnostics has raised $14.87 million across 6 funding rounds from investors including Smith & Nephew, Kent County Council and Octopus Investments. The company has 11 employees as of September 30, 2021. Michelson Diagnostics offers products and services including VivoSight OCT Scanner. Michelson Diagnostics operates in a competitive market with competitors including Castle Biosciences, DermTech, SpectraWAVE, NinePoint Medical and DermaSensor, among others.
- Headquarter Maidstone, United Kingdom
- Employees 11 as on 30 Sep, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Michelson Diagnostics Ltd
- Date of Incorporation 07 Mar, 2006
- Jurisdiction NOTTINGHAM, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.87 M (USD)
in 6 rounds
-
Latest Funding Round
$3.8 M (USD), Series B
Feb 09, 2015
-
Investors
Smith & Nephew
& 7 more
-
Employee Count
11
as on Sep 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Michelson Diagnostics
Michelson Diagnostics offers a comprehensive portfolio of products and services, including VivoSight OCT Scanner.
Provides non-invasive imaging for skin and tissue examination in clinics.
Funding Insights of Michelson Diagnostics
Michelson Diagnostics has successfully raised a total of $14.87M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $3.8 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Michelson Diagnostics
Michelson Diagnostics has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Smith & Nephew, Kent County Council and Octopus Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and support for founders in technology and health sectors.
|
Locked | Locked | Locked | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Locked | Locked | Locked | |
|
Manufacturer of knee, hip and shoulder joint replacements
|
Locked | Locked | Locked |
Investor details for Michelson Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Michelson Diagnostics
Investment portfolio details for Michelson Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Michelson Diagnostics
Detailed financials for Michelson Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Michelson Diagnostics Comparisons
Peer comparison for Michelson Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Michelson Diagnostics
Michelson Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, DermTech, SpectraWAVE, NinePoint Medical and DermaSensor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| Locked | Locked | Locked |
Biological tissue imaging is developed using optical coherence tomography.
|
Detailed competitors of Michelson Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Michelson Diagnostics
Complete news archive for Michelson Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Michelson Diagnostics
Michelson Diagnostics was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Michelson Diagnostics is headquartered in Maidstone, United Kingdom.
Michelson Diagnostics is a funded company, having raised a total of $14.87M across 6 funding rounds to date.
As of Sep 30, 2021, the latest employee count at Michelson Diagnostics is 11.
Michelson Diagnostics specializes in creating advanced medical imaging technology, including the VivoSight OCT scanner for non-invasive skin and tissue examination. The company operates from its headquarters in the UK, with additional offices in Germany and the US, focusing on optical coherence tomography innovations. They engage in partnerships, investments, and provide systems for clinical applications, emphasizing shareholder value and product development.
Michelson Diagnostics's top competitors include DermTech, DermaSensor and NinePoint Medical.
Michelson Diagnostics offers VivoSight OCT Scanner.
Michelson Diagnostics has 8 investors. Key investors include Smith & Nephew, Kent County Council, Octopus Investments, Catapult Ventures, and London Zu.